Observational Study for Patients With Hemoglobinopathies and Rare Inherited Anemia and Covid 19
Recruiting
Observational Study
Haemoglobinopathies
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Sex
- Any
- Study type
- Observational
- Participants needed
- 10,000 (estimated)
- Sponsor
- Società Italiana Talassemie ed Emoglobinopatie · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The COVID-19 pandemic is causing many deaths around the world, putting a strain on health services. Patients with pre-existing chronic conditions are most affected by the SARS-COV2 infection. Infectious complications are a common cause of mortality and one of the main causes of morbidity in all these diseases. The main objective of this project is the assessment of patients with thalassemia, drepa…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
INCLUSION CRITERIA:
* Patients with an established diagnosis of thalassemia, sickle cell disease, other haemoglobinopathies and Rare Anemia inherit with a virological diagnosis of SARS-COV-2 infection.
EXCLUSION CRITERIA:
* nobody
Contacts